Brief: Clearside Biomedical Asia-Pacific Partner Arctic Vision Announces Acceptance In Australia Of New Drug Application For Suprachoroidal Use Of Arcatus
10/07/2023 13:15
July 10 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL ASIA-PACIFIC PARTNER ARCTIC VISION
ANNOUNCES THE ACCEPTANCE IN AUSTRALIA OF ITS NEW DRUG
APPLICATION FOR SUPRACHOROIDAL USE OF ARCATUS® FOR THE TREATMENT
OF UVEITIC MACULAR EDEMA
Source text for Eikon: ID:nGNXb4xfQZ
Further company coverage: CLSD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials